Chunlei Zheng, PhD

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Chunlei Zheng is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine. He is also a Health Science Specialist at VA Boston Healthcare System. Dr. Zheng completed his PhD in Biophysics at Chinese Academy of Sciences. After graduation, he moved to Cleveland Clinic, where he received a postdoctoral fellowship from American Heart Association to study the protein trafficking in human diseases. Before joining Boston University, Dr. Zheng is a research scientist at Case Western Reserve University, where he received intensive biomedical informatics training.

With solid background in biology and medicine and expertise in genomics, computer science, and statistics, Dr. Zheng has great passion for data-driven biomedical discovery. In particular, he has great interest on developing/applying computational algorithm, machine learning and statistical modeling into large-scale biomedical data to facilitate disease understanding and drug discovery. Currently, his research focuses on using artificial intelligence (AI) on Alzheimer’s Disease and Cancer.

Publications

  • Published 9/16/2025

    Zheng C, Khan A, Ritter D, Marks DS, Do NV, Fillmore NR, Sander C. Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records. Cell Rep Med. 2025 Sep 16; 6(9):102359. PMID: 40961920.

    Read at: PubMed

  • Published 8/16/2025

    Schuster E, Dashzeveg NK, Tong F, Jia Y, El-Shennawy L, Zhang T, Hoffman AD, Kitata RB, Kibria G, Zhang Y, Squires JR, Zheng C, Ramos E, Taftaf R, Scholten D, Almubarak HF, Adorno-Cruz V, Sullivan DP, Reduzzi C, Minor AC, Purev-Ochir W, Spahija S, Xu R, Siziopikou KP, Platanias LC, Shah A, Muller WA, Gradishar WJ, Cristofanilli M, Tsai CF, Shi T, Liu H. Computational ranking identifies Plexin-B2 in circulating tumor cell clustering with monocytes in breast cancer metastasis. Nat Commun. 2025 Aug 16; 16(1):7649. PMID: 40818975.

    Read at: PubMed

  • Published 4/1/2025

    Larsen JR, Zheng C, La J, Wu JT, Kelley M, Gaziano JM, Brophy M, Do NV, Kim DH, Driver JA, DuMontier C, Fillmore NR. Multimorbidity and Its Impact in Older U.S. Veterans Newly Treated for Advanced Non-Small Cell Lung Cancer. Ann Am Thorac Soc. 2025 Apr; 22(4):598-608. PMID: 39680869.

    Read at: PubMed

  • Published 12/16/2024

    Pu JJ, Berger KN, Zheng C, Do N, Claxton DF, Ehmann WC, Drabick JJ, Li H, Loughran TP, Epner EM. A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma. Front Oncol. 2024; 14:1449401. PMID: 39737396.

    Read at: PubMed

  • Published 5/8/2024

    Ramos-Cejudo J, Corrigan JK, Zheng C, Swinnerton KN, Jacobson SR, La J, Betensky RA, Osorio RS, Madanes S, Pomara N, Iosifescu D, Brophy M, Do NV, Fillmore NR. Antidepressant exposure and long-term dementia risk in a nationwide retrospective study on US veterans with midlife major depressive disorder. Alzheimers Dement. 2024 Jun; 20(6):4106-4114. PMID: 38717046.

    Read at: PubMed

View All 40 Publications:   View Full Profile in BUMC

Websites

Education

  • Chinese Academy of Sciences, PhD
  • Shaanxi Normal University, BS

View all profiles